Securecell

Securecell is a diversified Swiss technology company with a dual focus on bioprocess automation (Biotech) and advanced medical monitoring systems (Medtech). Its core Biotech offering, the Lucullus® software platform, serves as a comprehensive SCADA system for digitalizing and controlling bioprocess development and manufacturing. In Medtech, the company is developing the disruptive Seraccess® technology, targeting automated, high-frequency blood monitoring with applications ranging from ICU glucose monitoring to a fully mobile artificial pancreas. Securecell combines product innovation with extensive customer support and training to drive efficiency and discovery in life sciences and healthcare.

Integrated hardware/software for bioprocess automation (Lucullus SCADA, automated sampling) and proprietary microfluidics for automated, high-frequency blood parameter monitoring (Seraccess®).

In Biotech, Securecell competes with large automation providers (e.g., Siemens, Emerson) and bioprocess specialists offering SCADA and PAT solutions. In Medtech, the Seraccess® platform would enter a highly competitive market dominated by major players like Dexcom, Abbott, and Medtronic in continuous glucose monitoring and insulin delivery systems.